Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
Op-Eds
Precautionary Principle May Do More Harm Than Good
Residents of a city facing a permanent threat from earthquakes know how important it is to exercise caution. Thus, it may seem reasonable for city,…
Op-Eds
Hormone Replacement Therapy Truth: It’s Not All Bad
Hormone Replacement Therapy has been all over the news since a recent trial revealed that HRT comes with some significant health risks. The trial,…
Op-Eds
EU Ratifies Biosafety Protocol
The European Union took yet another step away from the rational regulation of genetically modified crop plants and foods in late June, when it…
Op-Eds
Science vs. Presumption In Assessing Risk
Full Chapter Available in PDF Format On September 22, 2000, California Governor Gray Davis signed into…
Op-Eds
European move will stifle GMOs
Regulatory officials in the European Union seem to be ignorant of the Rule of Holes: When you're in a hole, stop digging. Repeated analyzes…
Op-Eds
Blessed Are The Poor With Spirit
This year's UN-sponsored World Food Summit just concluded with a grim reminder that the goal of cutting world hunger in half by 2015 set six…